Guidance Archives - Page 27 of 637

1 minute read

Change Healthcare Cyberattack: GoodRx Expects Low Single Digit Million-Dollar Impact In 2024

May 9, 2:24 PM

GoodRx's Q1 earnings: $0.08 EPS, sales hit $197.88 million, beating expectations fueled by prescription transactions and pharma solutions. Q2 forecast: ~$200 million revenue, optimistic 2024 outlook.

GDRX

2 minute read

Weak Sales From Lipitor, Norvasc Hurt Viatris’ Q1 Earnings, Lowers Annual Forecast

By Vandana Singh

May 9, 2:23 PM

Viatris reports Q1 EPS in line with consensus at $0.67, with sales slightly missing expectations at $3.66 billion. Strong growth in Emerging Markets and Europe offset by challenges in North America. Guidance adjusted slightly downward for 2024.

VTRS

2 minute read

Japan’s Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%

By Vandana Singh

May 9, 1:46 PM

Takeda Pharmaceutical (NYSE: TAK) reveals fiscal year 2023 results & restructuring plan. Revenue up 5.9%, net profit down 54.6%. Expecting operating profit of 225 billion yen in 2024.

TAK

1 minute read

Tower Semiconductor CEO Eyes Recovery, Projects Over 7% Growth Next Quarter

By Anusuya Lahiri

May 9, 1:39 PM

Tower Semiconductor (TSEM) reported Q1 2024 revenue of $327.24M, beating analyst estimates. CEO optimistic for recovery despite market downturn.

TSEM

1 minute read

Why Is Berry Global Group Stock Falling Today?

By Nabaparna Bhattacharya

May 9, 1:33 PM

Berry Global Group shares decline as Q2 revenue misses expectations despite beating EPS estimates, with net sales down 6% year over year.

BERY

1 minute read

NCR Voyix Q1 2024: Mixed Bag With Revenue Dip, Profit Beat

By Lekha Gupta

May 9, 1:26 PM

NCR Voyix Corp reports 6% decline in Q1 FY24 revenues to $862M, surpassing consensus. Software & Services revenue grows 2%. Outlook reiterated.

VYX

2 minute read

Cronos Cannabis Company Slashes Losses, Reports Highest Quarterly Net Revenue In Q1 2024

By Nicolas Jose Rodriguez

May 9, 1:18 PM

Cronos Group Inc., (NASDAQ: CRON) a global cannabinoid company, has reported an increase in net revenue for the first quarter of 2024.

CRON

1 minute read

Hanesbrands +5% After Q1 Results – Here’s Why

By Nabaparna Bhattacharya

May 9, 1:16 PM

Hanesbrands shares surge 5% after Q1 report, with adjusted EPS loss narrower than expected, boosted by increased gross profit margin.

HBI

2 minute read

Checking In: Hilton Grand Vacations’ Q1 Performance Exceeds Estimates, Backs Outlook

By Lekha Gupta

May 9, 12:52 PM

Hilton Grand Vacations Inc (HGV) reported Q1 FY24 sales of $1.16B, up from $934M last year. Adjusted EBITDA rose to $273M and EPS beat estimates at $0.95.

HGV

1 minute read

Why Is Madison Square Garden Stock Down Today?

By Lekha Gupta

May 9, 12:39 PM

Madison Square Garden Entertainment Corp. reported lower Q3 results with revenue of $228.3M, missing estimates. EPS of $0.06 beat expectations.

MSGE